TME Pharma

TME Pharma's Ordinary Shares

• Date of the IPO: September 28, 2016
• ISIN / Mnemo : NL0015000YE1 / ALTME
• Stock exchange: Euronext Growth Paris
• Fiscal year end : December 31
• Number of shares (June 18, 2024): 41,541,531*
• Liquidity contract: Invest Securities

*Taking into account the shares issuance following private placement and public offering on June 17, 2024.


Analyst Coverage

Firm:  Analyst: 
In Extenso  

Jean-Pierre Loza, PhD 

Invest Securities   Jamila El Bougrini, PhD
 
TME Pharma N.V. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding TME Pharma’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of TME Pharma or its management. TME Pharma does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

TME Pharma's Warrants Z

• ISIN NL0015001SR3
• Stock exchange: Euronext Growth Paris
• Number of Warrants Z (March 28, 2024): 3,326,104

 Rapid access to French brokers

        

 

 

We use cookies

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (Google Analytics cookies). You can decide for yourself whether you want to accept the cookies. Please note that if you refuse cookies, you may no longer be able to use all of the site's functions.